ABII: Summary for Abraxis Bioscience Inc. - Yahoo! Canada Finance

Abraxis Bioscience Inc. (NasdaqNM:ABII) Delayed quote data

Last Trade:	33.85 USD
Trade Time:	Nov 20
Change:	0.00 (0.00%)
Prev Close:	33.85
Open:	N/A
Bid:	N/A
Ask:	N/A
1y Target Est:	N/A

Day's Range:	N/A - N/A
52wk Range:	24.52 - 74.50
Volume:	0
Avg Vol (3m):	54,003
Market Cap:	1.36B
P/E (ttm):	N/A
EPS (ttm):	-1.03
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y

Free Annual Reports

Add ABII to Portfolio

Download Data

HEADLINES

•	Uncertainty Breeds Opportunity in Specialty Pharma Stock Pick From Piper Jaffray Senior Research Analyst
	Wall Street Transcript (Fri, Nov 20)

•	Healthcare Bill Will Be Law By New Year Says Morningstar Strategist
	Wall Street Transcript (Mon, Nov 9)

•	Morningstar Strategist Says Healthcare Bill Will Be Law By End Of Year: Is Your Portfolio Ready?
	Wall Street Transcript (Mon, Nov 9)

•	ABRAXIS BIOSCIENCE, INC. Files SEC form 10-Q, Quarterly Report
	EDGAR Online (Mon, Nov 9)

•	New Star Analyst Rankings for Abraxis Bioscience Inc.
	StarMine (Sun, Nov 8)

•	Abraxis opens expanded plant in Phoenix, expected to create 200 jobs
	at bizjournals.com (Thu, Nov 5)

•	Abraxis BioScience, Inc. Earnings Call scheduled for 11:30 am ET today
	CCBN (Thu, Nov 5)

•	Abraxis BioScience Reports 2009 Third Quarter Financial Results
	Business Wire (Thu, Nov 5)

•	ABRAXANE® Receives Orphan Drug Status for the Treatment of Pancreatic Cancer and Stage IIB-IV Melanoma
	Business Wire (Thu, Nov 5)

•	Q3 2009 Abraxis BioScience, Inc. Earnings Release - Before Market Open
	CCBN (Thu, Nov 5)

More Headlines for ABII...

BUSINESS SUMMARY

Abraxis Bioscience, Inc., a biotechnology company, delivers therapeutics and core technologies that offer patients and medical professionals treatments for cancer and other critical illnesses.

Full Company Profile

Add to Portfolio

Email to a Friend

•

	Sign In [New User? Sign Up]	Finance Home \|Help

Abraxis BioScience, Inc. (ABII)